ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Some oncogene-addicted cancers will have stereotyped genomic escape mechanisms, leading to progression (for example, ABL kinase domain mutations in CML [31] and gain of EGFR p.T790M mutation in EGFR-mutated lung adenocarcinoma [32]).